We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company is seeking further clearances for diagnosing or monitoring hypertension, chronic obstructive pulmonary disease, sleep apnea, worsening heart failure and post-surgical recovery. Read More
The test’s ability to predict how well bladder cancer patients will respond to therapy allows for “timely interventions that could result in more favorable outcomes,” the company said. Read More
The radial access selective catheter gained the CE mark for delivery of interventional devices into the peripheral, coronary and neuro vasculature. Read More
The device is currently under FDA review as part of the company’s rapid antimicrobial susceptibility test system for isolated bacterial colonies. Read More
The device offers a minimally invasive local microsurgery procedure to deal with the cyst that causes the condition and to restore patient brain function and development. Read More
LGC SeraCare says its AccuPlex technology mimics wild-type pathogenic viruses, but is safe, noninfectious and does not lead to replication in human cells. Read More